Immediate Impact
5 from Science/Nature 88 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Works of Jiantao Ma being referenced
Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease
2018
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jiantao Ma | 718 | 427 | 569 | 632 | 61 | 1.7k | |
| Ebe D’Adamo | 772 | 301 | 438 | 773 | 43 | 1.7k | |
| Mehmet Emre Atabek | 438 | 601 | 388 | 749 | 105 | 2.2k | |
| Yuni Choi | 505 | 396 | 384 | 407 | 51 | 1.8k | |
| R. Conde | 950 | 198 | 1081 | 693 | 133 | 2.2k | |
| Paloma Almeda‐Valdés | 763 | 154 | 459 | 777 | 90 | 2.1k | |
| Caterina Anania | 1014 | 152 | 399 | 609 | 53 | 1.9k | |
| Kun Song | 663 | 348 | 432 | 573 | 111 | 1.8k | |
| Yeong Sook Yoon | 637 | 536 | 487 | 492 | 54 | 2.2k | |
| Özgür Pirgon | 458 | 358 | 264 | 506 | 105 | 1.6k | |
| Shaomei Sun | 602 | 356 | 423 | 467 | 108 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...